Jiali Dong, Lu Lu, Saijun Fan. Progress in research on necroptosis as a target for cancer radiotherapy and chemotherapy[J]. Int J Radiat Med Nucl Med, 2017, 41(3): 220-226. DOI: 10.3760/cma.j.issn.1673-4114.2017.03.012
Citation: Jiali Dong, Lu Lu, Saijun Fan. Progress in research on necroptosis as a target for cancer radiotherapy and chemotherapy[J]. Int J Radiat Med Nucl Med, 2017, 41(3): 220-226. DOI: 10.3760/cma.j.issn.1673-4114.2017.03.012

Progress in research on necroptosis as a target for cancer radiotherapy and chemotherapy

  • A characteristic of cancer is resistance to programmed cell death, which sustains cell survival through oncogenic transformation and therapeutic resistance. Recent studies have shown that programmed cell death is not limited to caspase-dependent apoptosis. Necroptosis, a caspase-independent form of cell death, is regulated by receptor interacting protein 1, receptor interacting protein 3, and mixed lineage kinase domain-like proteins. This review summarized current research studies on necroptosis to provide perspectives for the development of novel tumor radiotherapy and chemotherapy strategies that target this process.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return